Dermatop is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat skin inflammation and itching associated with skin conditions that respond to corticosteroids. This medication is approved for use in individuals aged 1 year or older, although special care should be made when using Dermatop in young children. Dermatop is also known by its drug name, prednicarbate.
Dermatop is a corticosteroid of medium potency. Dermatop is believed to work by suppressing immune system activity.
How do I take it?
Prescribing information states that dermatop is applied topically to the affected area twice daily.
Dermatop comes in the form of an emollient cream.
The FDA-approved label for Dermatop lists common side effects including mild skin atrophy (thinning and wrinkling of skin and/or visible depressions), itchiness, swelling, burning, and rash.
Rare but serious side effects for corticosteroids include swelling, allergic contact dermatitis, high blood sugar, and reversible hypothalamic-pituitary-adrenal axis suppression (a dysfunction of the adrenal system).
For more details about this treatment, visit:
Dermatop — RxList
Prescription Topical Treatment — National Eczema Association